Page last updated: 2024-08-24

remacemide and Disease Models, Animal

remacemide has been researched along with Disease Models, Animal in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boehrer, A; Nehlig, A1
Bates, GP; Hockly, E1
Borchelt, DR; Chan, N; Coonfield, ML; Eaton, M; Fromholt, D; Gale, A; Morton, JL; Neslon, C; Ross, CA; Savonenko, AV; Schilling, G; Vorovich, E1
Borowicz, KK; Czuczwar, SJ; Luszczki, JJ; Malek, R; Patsalos, PN; Ratnaraj, N1
Borrelli, AR; Cregan, EF; Palmer, GC; Willett, F1
Anderson, DK; Farmer, JB; Lewis, AI; Upputuri, S; Zuccarello, M1
Andreassen, OA; Beal, MF; Dedeoglu, A; Ferrante, KL; Ferrante, RJ; Hersch, SM; Jenkins, BG1

Reviews

2 review(s) available for remacemide and Disease Models, Animal

ArticleYear
Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
    Current opinion in neurology, 2003, Volume: 16, Issue:4

    Topics: Acetamides; Animals; Antioxidants; Creatine; Disease Models, Animal; Evaluation Studies as Topic; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Peptides; Point Mutation; Riluzole; Thioctic Acid; Trinucleotide Repeats; Ubiquinone

2003
Neuroprotective properties of the uncompetitive NMDA receptor antagonist remacemide hydrochloride.
    Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765

    Topics: Acetamides; Animals; Anticonvulsants; Brain; Cats; Cell Survival; Cerebrovascular Disorders; Disease Models, Animal; Humans; Hypoxia, Brain; Ischemic Attack, Transient; Mice; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Rats; Rats, Inbred SHR; Receptors, N-Methyl-D-Aspartate; S100 Calcium Binding Protein G; Subarachnoid Hemorrhage

1995

Other Studies

5 other study(ies) available for remacemide and Disease Models, Animal

ArticleYear
Effects of remacemide in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.
    Epilepsy research, 2003, Volume: 52, Issue:3

    Topics: Acetamides; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Male; Rats; Rats, Mutant Strains; Rats, Wistar; Seizures

2003
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice.
    Experimental neurology, 2004, Volume: 187, Issue:1

    Topics: Acetamides; Animals; Celecoxib; Chlorpromazine; Coenzymes; Cyclooxygenase Inhibitors; Disease Models, Animal; Disease Progression; Dopamine Antagonists; Environment, Controlled; Female; Humans; Huntington Disease; Mice; Mice, Transgenic; Motor Activity; Motor Skills; Neuroprotective Agents; Phenotype; Pyrazoles; Sulfonamides; Superoxide Dismutase; Superoxide Dismutase-1; Survival Rate; Treatment Outcome; Ubiquinone

2004
Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Epilepsy & behavior : E&B, 2007, Volume: 11, Issue:1

    Topics: Acetamides; Algorithms; Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Electroshock; Epilepsy; Epilepsy, Tonic-Clonic; Male; Memory; Mice; Motor Skills; Phenobarbital; Phenytoin; Seizures; Valproic Acid

2007
Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits.
    Journal of neurotrauma, 1994, Volume: 11, Issue:6

    Topics: Acetamides; Animals; Anticonvulsants; Cerebral Angiography; Cerebrovascular Circulation; Disease Models, Animal; Ischemic Attack, Transient; Male; Rabbits; Receptors, N-Methyl-D-Aspartate; Subarachnoid Hemorrhage

1994
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Mar-01, Volume: 22, Issue:5

    Topics: Acetamides; Administration, Oral; Animals; Behavior, Animal; Body Weight; Brain; Cerebral Ventricles; Coenzymes; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Organ Size; Survival Rate; Treatment Outcome; Ubiquinone

2002